Original Article| Volume 23, ISSUE 6, P1599-1603, July 2014

Analysis of the Interleukin-1 Receptor Antagonist Gene Variable Number Tandem Repeats in Ischemic Stroke


      There is an increasing interest in the role of inflammatory mechanisms contributing to the development of stroke. Recent studies have reported an association between allele 2 of a variable number tandem repeat of the interleukin-1 receptor antagonist (IL1RN) gene in Caucasian patients with ischemic stroke. The purpose of this investigation is to independently confirm these results in our study population.


      We recruited and genotyped 516 Caucasian patients with ischemic stroke and 380 matched controls. Tests of association were performed to estimate odds ratio (OR) for the IL1RN gene variable number tandem repeat polymorphism with case–control status. Genotype frequencies of IL1RN gene were compared by case–control and symptom status using χ2 contingency tables and logistic regression models.


      No significant association was observed between any of the IL1RN gene genotypes and ischemic stroke. The unadjusted association model a, and the fully saturated model e, adjusted for age, gender, and stroke risk factors demonstrated no significant increase in risk associated with the IL1RN gene 2/2 genotype (a: OR, 1.11; 95% confidence interval [CI], .67-1.89; P = .615; and e: OR, .95; 95% CI, .46-1.94; P = .574). Analyses of genotypic and allelic frequencies of each Trial of Org 10172 in Acute Stroke Treatment subtype with control and pairwise comparison between stroke subtypes did not show any significant differences in their distributions, and all P values were greater than the significance level of .05.


      Our results do not confirm an association between the gene and ischemic stroke in Caucasian patients.

      Key Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of Stroke and Cerebrovascular Diseases
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Hassan A.
        • Markus H.S.
        Genetics and ischaemic stroke.
        Brain. 2000; 123: 1784-1812
        • DeGraba T.J.
        Immunogenetic susceptibility of atherosclerotic stroke: implications on current and future treatment of vascular inflammation.
        Stroke. 2004; 35: 2712-2719
        • Dinarello C.A.
        Biologic basis for interleukin-1 in disease.
        Blood. 1996; 87: 2095-2147
        • Tarlow J.K.
        • Blakemore A.I.
        • Lennard A.
        • et al.
        Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat.
        Hum Genet. 1993; 91: 403-404
        • Witkin S.S.
        • Gerber S.
        • Ledger W.J.
        Influence of interleukin-1 receptor antagonist gene polymorphism on disease.
        Clin Infect Dis. 2002; 34: 204-209
        • Worrall B.B.
        • Azhar S.
        • Nyquist P.A.
        • et al.
        Interleukin-1 receptor antagonist gene polymorphisms in carotid atherosclerosis.
        Stroke. 2003; 34: 790-793
        • Francis S.E.
        • Camp N.J.
        • Dewberry R.M.
        • et al.
        Interleukin-1 receptor antagonist gene polymorphism and coronary artery disease.
        Circulation. 1999; 99: 861-866
        • Worrall B.B.
        • Brott T.G.
        • Brown Jr., R.D.
        • et al.
        IL1RN VNTR polymorphism in ischemic stroke: analysis in 3 populations.
        Stroke. 2007; 38: 1189-1196
        • Adams Jr., H.P.
        • Bendixen B.H.
        • Kappelle L.J.
        • et al.
        Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial.TOAST.Trial of Org 10172 in Acute Stroke Treatment.
        Stroke. 1993; 24: 35-41
        • Mansfield J.C.
        • Holden H.
        • Tarlow J.K.
        • et al.
        Novel genetic association between ulcerative colitis and the anti-inflammatory cytokine interleukin-1 receptor antagonist.
        Gastroenterology. 1994; 106: 637-642
        • Olsson S.
        • Holmegaard L.
        • Jood K.
        • et al.
        Genetic variation within the interleukin-1 gene cluster and ischemic stroke.
        Stroke. 2012; 43: 2278-2282
      1. The NINDS Stroke Genetics Network (SiGN) Study Investigators. Stroke Subtypes in Hispanic Patients in the NINDS Stroke Genetics Network (SiGN): a comparison of two classification systems. International Stroke Conference in February 2012. Abstract# 3884.

        • Markus H.S.
        Stroke genetics: prospects for personalized medicine.
        BMC Med. 2012; 10: 113